Cargando…

Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium

PURPOSE: To further evaluate the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents in management of primary pterygium. METHODS: Randomized controlled trials (RCTs) in databases of PubMed, Web of Science, Embase, and the Cochrane Central Register of Controlled Trials were s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bowen, Dong, Xingmei, Sun, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242018/ https://www.ncbi.nlm.nih.gov/pubmed/37287747 http://dx.doi.org/10.3389/fmed.2023.1166957

Ejemplares similares

Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis
por: Lai, Shih-Chung, et al.
Publicado: (2023)

Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor
por: Park, Choul Yong, et al.
Publicado: (2011)

Efficacy and Safety of Bevacizumab in the Treatment of Pterygium: An Updated Meta-Analysis of Randomized Controlled Trials
por: Sun, Yi, et al.
Publicado: (2018)

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
por: Jiang, Lin, et al.
Publicado: (2023)

Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases
por: Ventrice, Pasquale, et al.
Publicado: (2013)

Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China
por: Yang, Kai-Bo, et al.
Publicado: (2020)

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão, Miguel, et al.
Publicado: (2017)

Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012)

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
por: Kang, Hyun Goo, et al.
Publicado: (2018)

Evaluation of the Safety and Efficacy of a Low-Temperature Plasma Surgical System for Pterygium
por: Huang, Haixiang, et al.
Publicado: (2020)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

Stocker's line in pterygium
por: Arai, Yusuke, et al.
Publicado: (2017)

Induction of endothelial RAGE expression in pterygium
por: Al-Swailem, Samar, et al.
Publicado: (2014)

Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
por: Li, Yun-Fei, et al.
Publicado: (2022)

Vascular Endothelial Growth Factor B and Its Signaling
por: Lal, Nathaniel, et al.
Publicado: (2018)

Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium
por: Lee, Jun Seok, et al.
Publicado: (2017)

Efficacy of anti-vascular endothelial growth factor agents for treating neovascular age-related macular degeneration in vitrectomized eyes
por: Mun, Yongseok, et al.
Publicado: (2021)

The influence of pterygium on corneal densitometry evaluated using the Oculus Pentacam system
por: Zhang, Jing, et al.
Publicado: (2023)

Intravitreal Anti Vascular Endothelial Growth Factor Agents in The Management of Retinal Diseases: An Audit
por: Fiebai, Bassey, et al.
Publicado: (2017)

Current perspectives on use of anti-vascular endothelial growth factor agents for retinal disorders
por: Sengupta, Sabyasachi
Publicado: (2021)

Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure
por: Hannappe, Marc-Antoine, et al.
Publicado: (2022)

Mechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis
por: Miller, Bronte, et al.
Publicado: (2022)

Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline
por: Nikkhah, Homayoun, et al.
Publicado: (2018)

Two-Week Central Macular Thickness Reduction Rate >37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion
por: Zhou, Jialin, et al.
Publicado: (2022)

Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
por: Maitra, Puja, et al.
Publicado: (2023)

Evaluating the Efficacy and Safety of Different Pterygium Surgeries: A Review of the Literature
por: Palewski, Marcin, et al.
Publicado: (2022)

Anti-vascular endothelial growth factor in ophthalmology
por: Sinha, Rajesh, et al.
Publicado: (2009)

Optical Coherence Tomography Angiography-Based Quantitative Assessment of Morphologic Changes in Active Myopic Choroidal Neovascularization During Anti-vascular Endothelial Growth Factor Therapy
por: Wang, Yao, et al.
Publicado: (2021)

Efficacy and Safety of Anti–Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison
por: Zhang, Yun, et al.
Publicado: (2021)

Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents
por: Nagpal, Manish, et al.
Publicado: (2009)

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of coats' disease in children
por: Kaul, Shalini, et al.
Publicado: (2010)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
por: Ratra, Dhanashree
Publicado: (2021)

Comparison of vascular endothelial growth factor/vascular endothelial growth factor receptor 2 expression and its relationship to tumor cell proliferation in canine epithelial and mesenchymal tumors
por: KIMURA, Mayu, et al.
Publicado: (2021)

A Novel System for Measuring Pterygium's Progress Using Deep Learning
por: Wan, Cheng, et al.
Publicado: (2022)

Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
por: Huang, Shi-tong, et al.
Publicado: (2018)

Amniotic membrane transplantation and conjunctival autograft combined with mitomycin C for the management of primary pterygium: A systematic review and meta-analysis
por: Taher, Nada Omar, et al.
Publicado: (2022)

Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
por: Jain, Prashant, et al.
Publicado: (2018)

Visual outcome and efficacy of conjunctival autograft, harvested from the body of pterygium in pterygium excision
por: Bhandari, Vipul, et al.
Publicado: (2015)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
por: Chatziralli, Irini, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9dica8m1jusptog47cm7i2gios